The present invention relates to a compound of formula (I) wherein A, Z, L, R1, R2, R3, R4, R5and R33are as defined in claim 1, or a pharmaceutically acceptable salt thereof. The compounds of formula (I) possess utility as inhibitors of TEAD. The compounds are useful as medicaments in the treatment of diseases or conditions wherein inhibition of TEAD is desired, such as cancer and chronic pain.
[EN] PYRIDINES, PYRIMIDINES, AND PYRAZINES, AS BTK INHIBITORS AND USES THEREOF<br/>[FR] PYRIDINES, PYRIMIDINES, ET PYRAZINES, À TITRE D'INHIBITEURS DE BTK ET LEURS UTILISATIONS
申请人:MERCK PATENT GMBH
公开号:WO2015017502A1
公开(公告)日:2015-02-05
The present invention relates to pyridine, pyrimidine, and pyrazene compounds, and pharmaceutically acceptable compositions thereof, useful as BTK inhibitors.
PYRIDINES, PYRIMIDINES, AND PYRAZINES, AS BTK INHIBITORS AND USES THEREOF
申请人:MERCK PATENT GMBH
公开号:US20160159804A1
公开(公告)日:2016-06-09
The present invention relates to pyridine, pyrimidine, and pyrazene compounds, and pharmaceutically acceptable compositions thereof, useful as BTK inhibitors.